Sage Therapeutics, Inc. (SAGE)
Today's Latest Price: $71.75 USD
Updated Dec 4 4:00pm
Add SAGE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
Sage Therapeutics Inc (SAGE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SAGE.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 20 | $190 | $60 | $97.65 | $69.86 | 39.78% |
SAGE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 13 | 1 | 7 | 0 | 0 | 21 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The percent of analysts bearish on the stock of SAGE is lower than just about 100% of all US stocks.
- The number of analysts covering the stock of SAGE is higher than 98.64% of stocks in the mid market cap category.
- The variance in analysts' estimates of SAGE is less than 1.59999999999999% of stocks in the mid market cap category.
- The average analyst price target of SAGE is greater than 90.85% of Pharmaceutical Products stocks.
- SAGE has a higher upside potential (average analyst target price relative to current price) than 88.23% of stocks in the mid market cap category.
- Sage Therapeutics Inc's percentage of analysts bullish on the stock is higher than 27.65% of Pharmaceutical Products stocks.
- SAGE has a less change in bullishness amongst analysts than just about 100% of all US stocks.
Stocks similar to Sage Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GBT, BLUE and ALNY.
Make investment decisions regarding SAGE using the data that counts. Try POWR Ratings for free.